Elder Patients
Showing all 14 results
-
Asthma
We’re looking for individuals to participate in a clinical trial for a new asthma treatment. Help us improve care and get compensated for your time! Criteria & Qualifications: • Must be 12 years or older. • Diagnosed with asthma for at least 6 months. • Must be able to provide medical records. Compensation: Contact us for more information
Asthma
Read more -
Atopic Dermatitis
This clinical trial aims to explore and evaluate biomarkers associated with Atopic Dermatitis in individuals diagnosed with the condition. Criteria & Qualifications: • Open to males and females in good general health. • Individuals willing to participate and follow the study protocol. • Participants who can provide relevant medical records. Compensation: Contact us for more information
Atopic Dermatitis
Read more -
Chronic Obstructive Pulmonary Disease (COPD)
Join our study on Chronic Obstructive Pulmonary Disease (COPD) to evaluate therapies improving lung function and daily life. We aim to enhance treatment of this progressive respiratory condition.
Criteria & Qualifications: • Aged 40-80, diagnosed with COPD confirmed by spirometry.
• Current or former smoker with at least 10 pack-years smoking history.
• Must have cardiovascular risk such as hypertension, diabetes, or history of heart disease.
Compensation: Contact us for more informationChronic Obstructive Pulmonary Disease (COPD)
Read more -
COVID-19 Treatment
Participate in a COVID-19 treatment study to help prevent severe illness. Join us in advancing research for high-risk individuals. Criteria & Qualifications: • Must be 18 years or older and diagnosed with COVID-19 within the last 4 days. • Experiencing at least 2 symptoms like cough, fatigue, fever, or shortness of breath in the last 4 days. • Have one or more high-risk factors such as advanced age (75+), immunosuppression, or certain chronic conditions like lung disease or obesity (BMI ≥ 35). Compensation: Contact us for more information.
COVID-19 Treatment
Read more -
Device for COVID, Flu and RSV
Help us improve understanding of respiratory infections like COVID-19, Flu A, Flu B, and RSV. Criteria & Qualifications: • Must have symptoms such as cough, fatigue, or sore throat that started within the last 7 days. • Must not currently have nasal trauma (e.g., nosebleeds) or have used nasal rinses recently. • Must not be undergoing treatment for COVID-19 or flu within the past 14 days. Compensation: Contact us for more information.
Device for COVID, Flu and RSV
Read more -
End-stage kidney disease
We are conducting a clinical trial for patients with End-Stage Kidney Disease (ESKD) undergoing maintenance dialysis. Your participation can help advance treatment options for this condition. Criteria & Qualifications: • Are 18 years or older. • Have been receiving dialysis for at least 12 weeks. • Have been diagnosed with diabetes or cardiovascular disease. Compensation: Contact us for more information
End-stage kidney disease
Read more -
Eosinophilic Asthma
Asthma is a chronic condition that inflames and narrows the airways, causing difficulty breathing. Symptoms include coughing, wheezing, shortness of breath, and chest tightness.
Criteria & Qualifications: • Must be 12 years or older.
• Must have an Asthma diagnosis.
• Must be able to provide medical records.
Compensation: Up to $1,500Eosinophilic Asthma
Read more -
Erosive Esophagitis
Contribute to advancing the treatment of Erosive Esophagitis (GERD) by participating in a study focused on improving care and managing symptoms effectively. Criteria & Qualifications: • Must be 18–85 years old. • Experiencing heartburn and regurgitation within the last 7 days before the screening visit. • Able to attend all required visits during the study period. Compensation: Up to $1,300.
Erosive Esophagitis
Read more -
NASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis. • Cannot join if you have other liver diseases or a history of chronic alcohol use. Compensation: Contact us for more information
NASH
Read more -
NASH/MASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH.
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000.NASH/MASH Study
Read more -
NASH/MASH Trial
NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments.
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact us for more information.NASH/MASH Trial
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications:
• Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.
Compensation: Contact us for more informationRespiratory Syncytial Virus (RSV)
Read more -
Respiratory Syncytial Virus (RSV) Study
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply. Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days. • Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization. • Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition. Compensation: Contact us for more information
Respiratory Syncytial Virus (RSV) Study
Read more -
Ulcerative Colitis Trial
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis. Criteria & Qualifications: • Is at least 16 years of age or older. • Is willing to provide medical records. • Must have active symptoms, such as rectal bleeding. Compensation: Contact us for more information
Ulcerative Colitis Trial
Read more